QIAGEN N.V. QGEN
$ 42.32
0.47%
Annual report 2023
added 11-16-2024
Country |
Niderland |
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NYSE |
CEO |
Mr. Thierry Bernard |
Employees in the company |
5 300 |
Shares |
228 M |
Market Cap[1] |
$ 9.66 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Diagnostics research"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.